Bristol-Myers Squibb Co
NYSE:BMY
Wall Street
Price Targets
BMY Price Targets Summary
Bristol-Myers Squibb Co
According to Wall Street analysts, the average 1-year price target for BMY is 57.071 USD with a low forecast of 40.4 USD and a high forecast of 78.75 USD.
BMY Last Price Targets
Bristol-Myers Squibb Co
The latest public price target was made on Jan 30, 2024 by James Shin from Deutsche Bank , who expects BMY stock to rise by 23% over the next 12 months. You can read more about this price target by viewing the article on Benzinga.
Analyst | Price Target | Date | Article |
---|---|---|---|
James Shin
Deutsche Bank
|
55
USD
Upside 23% |
2 months ago
Jan 30, 2024
|
Did You Miss These 3 High-Yielding Dividend Stocks In Health Care Sector From Wall Street's Most Accurate Analysts?
Benzinga
|
Evan Seigerman
BMO Capital
|
60
USD
Upside 34% |
4 months ago
Nov 27, 2023
|
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields
Benzinga
|
David Risinger
Leerink Partners
|
66
USD
Upside 48% |
6 months ago
Oct 12, 2023
|
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields
Benzinga
|
Louise Chen
Cantor Fitzgerald
|
75
USD
Upside 68% |
7 months ago
Sep 6, 2023
|
How To Earn $500 From Pfizer Stock With Shares Trading At 52-Week Low
Benzinga
|
Operating Income
Forecast
Operating Income Estimate
Bristol-Myers Squibb Co
For the last 8 years the compound annual growth rate for Bristol-Myers Squibb Co's operating income is 23%. The projected CAGR for the next 3 years is 14%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is BMY's stock price target?
Price Target
57.071
USD
According to Wall Street analysts, the average 1-year price target for BMY is 57.071 USD with a low forecast of 40.4 USD and a high forecast of 78.75 USD.
What is Bristol-Myers Squibb Co's Revenue forecast?
Projected CAGR
0%
For the last 8 years the compound annual growth rate for Bristol-Myers Squibb Co's revenue is 13%. The projected CAGR for the next 3 years is 0%.
What is Bristol-Myers Squibb Co's Operating Income forecast?
Projected CAGR
14%
For the last 8 years the compound annual growth rate for Bristol-Myers Squibb Co's operating income is 23%. The projected CAGR for the next 3 years is 14%.
What is Bristol-Myers Squibb Co's Net Income forecast?
Projected CAGR
19%
For the last 8 years the compound annual growth rate for Bristol-Myers Squibb Co's net income is 23%. The projected CAGR for the next 3 years is 19%.